跳至主要内容
临床试验/NL-OMON26487
NL-OMON26487尚未招募不适用

nravelling the mechanism of action of low-dose glucocorticoids: a study of oral versus parenteral glucocorticoids.

VUmc0 个研究点目标入组 35 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
VUmc
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Reumatoid arthritis, polymyalgia rheumatica or psoriatic arthritis according to the treating physician
  • -Elevated ESR (=30 mm/h)

排除标准

  • Difficult to measure a decreased ESR
  • -Current or recent (<4 weeks previously) on any form of GC therapy
  • -For reumatoid arthritis and psoriatic arthritis patients, change of antirheumatic medication (DMARDs, biologics) in the 4 weeks before the assessment
  • -Known with other health conditions that can cause elevated ESR (e.g. hematologic disorders, infections, multiple myeloma, monoclonal gammopathy etc.)
  • Risk of harm
  • -Active disease necessitating (change of) treatment within weeks, according to treating physician
  • -Unstable medical condition causing contra-indication for GC, according to treating physician. For example active infection, unstable diabetes, malignant hypertension, etc.
  • -Signs or symptoms of temporal arteritis (according to the treating physician)

研究者

发起方
VUmc

相似试验